Class effects of statins in elderly patients with congestive heart failure: A population-based analysis

Division of Cardiology, Department of Medicine, Centre Hospitalier de l'Université de Montréal, University of Montreal, Montreal, Quebec, Canada.
American heart journal (Impact Factor: 4.46). 03/2008; 155(2):316-23. DOI: 10.1016/j.ahj.2007.09.004
Source: PubMed


Long-term treatment with statins reduces mortality in patients with congestive heart failure (CHF). Whether statin agents exert a class effect is unknown.
We analyzed long-term mortality in Canadian patients aged > or = 65 years who were discharged from hospital with a diagnosis of CHF from January 1998 to December 2002. Administrative data from Quebec, Ontario, and British Columbia were merged. We compared patients prescribed with atorvastatin, simvastatin, pravastatin, and lovastatin.
A total of 15,368 patients hospitalized with a diagnosis of CHF fulfilled the inclusion criteria for this study. In this final dataset, 6670 (43.4%) filled a prescription for atorvastatin, 4261 (27.7%) for simvastatin, 3209 (20.9%) for pravastatin, and 1228 (8.0%) for lovastatin. Clinical characteristics and proportion of days covered with a statin prescription were similar across groups. Drug dosages were relatively low, with 82% of patients who received the agent at a dose of < or = 20 mg. Although controlling for time-dependent covariates representing current use and dosage, as well as for age, sex, coronary artery disease, and several other comorbidities, treatment with pravastatin (adjusted hazards ratio [HR] 0.94, 95% CI 0.83-1.07), lovastatin (adjusted HR 1.02, 95% CI 0.88-1.17), or simvastatin (adjusted HR 0.92, 95% CI 0.83-1.01) had a similar effectiveness to prevent mortality compared to atorvastatin (reference in this analysis) in this population with CHF. Time-dependent exposure to a statin was highly protective against mortality.
Statins exert a class effect in patients with CHF, when used at a relatively low dose. The favorable effects appear largely independent of drug dosage.

Download full-text


Available from: Karin H Humphries,
  • [Show abstract] [Hide abstract]
    ABSTRACT: This article contains a review of the main developments in the field of geriatric cardiology reported during 2007, and discusses recent consensus statements. The article focuses on work dealing with the specific characteristics of elderly patients with ischemic heart disease, arrhythmias, heart failure, pulmonary hypertension and valvular heart disease.

  • Heart Failure Clinics 05/2008; 4(2):ix-xii. DOI:10.1016/j.hfc.2008.03.012 · 1.84 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Statins are effective in the prevention of an atherosclerotic event, e.g. coronary artery disease and cerebrovascular disease. Patients at high risk of cardiovascular disease (CVD), such as chronic heart failure (CHF), might benefit from the effects of statin therapy. However, one question that has not yet been answered and that may clarify the role of statins in CHF is whether statins prevent the development of CHF in patients with a low risk of CVD. Our aim was to evaluate the impact of adherence to statins on the incidence of CHF. A cohort of 111,481 patients was reconstructed using the Régie de l'Assurance Maladie du Québec databases. Patients were eligible if they were between 45 and 85 years old, without CVD, and newly treated with statins between 1999 and 2004. A nested case-control design was used to study CHF. Every case of CHF was matched for age and duration of follow-up in up to 15 randomly selected controls. The adherence level was measured by calculating the medication possession ratio. Rate ratios (RR) of CHF were estimated by conditional logistic regression adjusting for several covariables. The mean patient age was 63 years, 49% had hypertension, 21% had diabetes and 41% were male. A high level of adherence to statins was associated with a reduction of CHF (RR 0.81; 0.71, 0.91). The risks associated with CHF were the development of CVD during follow-up, being a social-aid recipient, and suffering from hypertension, diabetes mellitus, or having a higher chronic disease score. Our study indicates that better adherence to statins is associated with a reduced risk of CHF.
    British Journal of Clinical Pharmacology 08/2008; 66(5):706-16. DOI:10.1111/j.1365-2125.2008.03269.x · 3.88 Impact Factor
Show more